Nifty
:
24450.45
Sensex
:
78918.90
-315.45 (-1.27%)
-1097.00 (-1.37%)
Nifty
Sensex
:
:
24450.45
78918.90
-315.45 (-1.27%)
-1097.00 (-1.37%)

Lincoln Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :
67/99

BSE: 531633 | NSE: LINCOLN

NSE BSE
616.75
06-Mar-2026
  • Open
  • High
  • Low
  • Previous Close
  •  622.85
  •  622.9
  •  616
  •  622.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  11947
  •  7385795.8
  •  677
  •  440

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,235.83
  • 14.07
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,212.91
  • 0.29%
  • 1.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.78%
  • 1.35%
  • 36.28%
  • FII
  • DII
  • Others
  • 4.7%
  • 0.00%
  • 7.89%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.53
  • 8.00
  • 6.89

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.61
  • 3.09
  • 2.62

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.27
  • 5.76
  • 4.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.55
  • 12.04
  • 13.21

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.64
  • 1.75
  • 1.90

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.18
  • 7.82
  • 8.81

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
166.32
146.55
13.49%
163.36
161.21
1.33%
154.07
147.28
4.61%
168.18
142.49
18.03%
Expenses
142.73
122.89
16.14%
137.94
132.83
3.85%
130.26
124.55
4.58%
141.46
124.11
13.98%
EBITDA
23.60
23.66
-0.25%
25.43
28.38
-10.39%
23.81
22.73
4.75%
26.72
18.38
45.38%
EBIDTM
14.19%
16.15%
15.57%
17.60%
15.45%
15.43%
15.89%
12.90%
Other Income
15.15
8.97
68.90%
7.23
9.98
-27.56%
15.27
10.41
46.69%
-6.88
7.02
-
Interest
0.30
0.73
-58.90%
0.23
0.35
-34.29%
0.21
0.44
-52.27%
0.37
0.50
-26.00%
Depreciation
3.72
3.22
15.53%
3.62
3.22
12.42%
3.48
3.22
8.07%
3.23
2.69
20.07%
PBT
34.72
28.68
21.06%
28.81
34.78
-17.17%
35.39
29.48
20.05%
16.25
22.22
-26.87%
Tax
6.12
7.91
-22.63%
8.83
8.45
4.50%
7.71
5.81
32.70%
4.67
3.62
29.01%
PAT
28.60
20.77
37.70%
19.98
26.33
-24.12%
27.68
23.67
16.94%
11.57
18.60
-37.80%
PATM
17.20%
14.17%
12.23%
16.33%
17.96%
16.07%
6.88%
13.05%
EPS
14.28
10.37
37.70%
9.98
13.15
-24.11%
13.82
11.82
16.92%
5.78
9.28
-37.72%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
651.93
623.23
580.55
510.31
472.12
424.19
386.49
366.15
360.61
360.26
400.15
Net Sales Growth
9.10%
7.35%
13.76%
8.09%
11.30%
9.75%
5.56%
1.54%
0.10%
-9.97%
 
Cost Of Goods Sold
302.23
202.66
204.07
179.43
169.71
155.86
138.15
135.66
156.44
202.90
254.64
Gross Profit
349.70
420.57
376.48
330.88
302.41
268.32
248.34
230.49
204.18
157.35
145.50
GP Margin
53.64%
67.48%
64.85%
64.84%
64.05%
63.25%
64.26%
62.95%
56.62%
43.68%
36.36%
Total Expenditure
552.39
521.74
480.64
421.11
376.64
337.01
320.95
298.91
308.30
313.52
359.62
Power & Fuel Cost
-
11.66
11.47
10.25
8.33
7.10
8.18
7.21
6.82
5.92
5.68
% Of Sales
-
1.87%
1.98%
2.01%
1.76%
1.67%
2.12%
1.97%
1.89%
1.64%
1.42%
Employee Cost
-
112.45
102.90
93.16
79.72
63.26
58.65
51.90
51.15
37.59
28.83
% Of Sales
-
18.04%
17.72%
18.26%
16.89%
14.91%
15.18%
14.17%
14.18%
10.43%
7.20%
Manufacturing Exp.
-
121.54
102.35
85.72
69.33
61.54
64.05
60.71
51.73
29.44
35.81
% Of Sales
-
19.50%
17.63%
16.80%
14.68%
14.51%
16.57%
16.58%
14.35%
8.17%
8.95%
General & Admin Exp.
-
39.46
29.91
31.06
27.56
23.06
21.30
20.98
17.50
14.78
20.34
% Of Sales
-
6.33%
5.15%
6.09%
5.84%
5.44%
5.51%
5.73%
4.85%
4.10%
5.08%
Selling & Distn. Exp.
-
30.87
26.71
19.20
19.49
24.54
26.79
20.02
21.24
19.91
10.10
% Of Sales
-
4.95%
4.60%
3.76%
4.13%
5.79%
6.93%
5.47%
5.89%
5.53%
2.52%
Miscellaneous Exp.
-
3.10
3.23
2.28
2.51
1.64
3.83
2.43
3.44
2.97
10.10
% Of Sales
-
0.50%
0.56%
0.45%
0.53%
0.39%
0.99%
0.66%
0.95%
0.82%
1.05%
EBITDA
99.56
101.49
99.91
89.20
95.48
87.18
65.54
67.24
52.31
46.74
40.53
EBITDA Margin
15.27%
16.28%
17.21%
17.48%
20.22%
20.55%
16.96%
18.36%
14.51%
12.97%
10.13%
Other Income
30.77
22.48
34.42
22.47
10.00
5.66
11.04
5.63
5.45
2.78
7.36
Interest
1.11
1.88
1.46
2.03
1.45
1.56
2.02
4.00
5.41
6.66
9.96
Depreciation
14.05
12.90
10.62
9.17
8.09
7.56
7.33
6.68
6.11
5.51
4.87
PBT
115.17
109.19
122.24
100.48
95.94
83.72
67.23
62.19
46.25
37.33
33.07
Tax
27.33
26.84
28.94
27.58
26.58
21.47
15.77
13.46
11.60
9.20
9.27
Tax Rate
23.73%
24.58%
23.67%
27.45%
27.70%
25.65%
23.46%
21.64%
25.08%
24.65%
28.03%
PAT
87.83
82.35
93.30
72.90
69.36
62.25
51.44
48.71
34.62
28.12
23.68
PAT before Minority Interest
87.83
82.35
93.30
72.90
69.36
62.25
51.47
48.74
34.65
28.13
23.80
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.01
-0.12
PAT Margin
13.47%
13.21%
16.07%
14.29%
14.69%
14.68%
13.31%
13.30%
9.60%
7.81%
5.92%
PAT Growth
-1.72%
-11.74%
27.98%
5.10%
11.42%
21.01%
5.60%
40.70%
23.12%
18.75%
 
EPS
43.92
41.18
46.65
36.45
34.68
31.13
25.72
24.36
17.31
14.06
11.84

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
671.67
592.84
502.47
432.88
366.39
313.09
269.34
224.22
192.38
140.52
Share Capital
20.03
20.03
20.03
20.03
20.03
20.00
20.00
20.00
20.00
16.31
Total Reserves
651.64
572.81
482.44
412.85
346.36
293.09
249.34
204.22
172.38
116.65
Non-Current Liabilities
19.12
15.18
38.02
10.99
26.10
42.85
28.43
24.94
31.75
33.74
Secured Loans
0.00
0.00
0.00
0.00
0.14
0.85
1.69
6.93
12.38
23.62
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.73
0.10
25.36
0.00
15.98
32.51
17.49
7.19
9.98
0.00
Current Liabilities
131.09
117.41
96.01
110.71
94.78
80.32
100.37
113.48
99.42
100.34
Trade Payables
84.95
72.44
50.87
71.67
57.07
51.24
44.01
43.42
32.46
30.38
Other Current Liabilities
14.78
15.18
14.51
9.84
13.43
9.13
11.11
11.11
12.77
15.10
Short Term Borrowings
0.00
1.07
2.00
2.04
0.00
3.83
30.09
48.55
45.04
52.62
Short Term Provisions
31.36
28.73
28.64
27.16
24.28
16.11
15.16
10.41
9.15
2.24
Total Liabilities
821.88
725.43
636.50
554.58
487.27
436.64
398.50
362.97
323.85
274.79
Net Block
181.97
179.33
150.53
131.88
110.64
122.72
120.91
116.58
102.71
98.47
Gross Block
251.98
236.65
197.47
171.07
141.90
146.70
138.11
127.65
108.16
120.89
Accumulated Depreciation
70.01
57.32
46.95
39.19
31.26
23.98
17.21
11.08
5.45
22.42
Non Current Assets
297.07
262.51
245.42
181.51
159.59
173.91
159.43
136.08
134.27
127.83
Capital Work in Progress
4.47
3.48
6.71
16.05
1.69
0.04
2.10
0.29
6.63
2.73
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.09
0.09
0.09
0.09
0.01
Long Term Loans & Adv.
110.63
79.70
88.18
31.83
46.81
51.02
36.01
18.79
24.48
26.62
Other Non Current Assets
0.00
0.00
0.00
1.75
0.45
0.03
0.33
0.34
0.36
0.00
Current Assets
524.81
462.91
391.08
373.07
327.69
262.73
239.08
226.88
189.58
146.98
Current Investments
173.72
138.92
91.33
96.81
80.66
34.22
18.07
10.97
10.25
0.00
Inventories
78.68
77.17
70.03
72.74
46.61
47.40
36.23
45.41
37.31
27.48
Sundry Debtors
166.40
161.77
136.33
115.94
113.35
101.34
122.47
109.44
90.67
80.53
Cash & Bank
22.43
13.83
34.32
18.80
13.84
14.58
7.58
14.59
11.68
12.66
Other Current Assets
83.59
1.69
2.10
1.19
73.22
65.20
54.74
46.47
39.68
26.31
Short Term Loans & Adv.
80.95
69.54
56.98
67.59
71.79
64.09
53.64
45.18
39.02
26.26
Net Current Assets
393.72
345.50
295.07
262.36
232.91
182.41
138.71
113.40
90.16
46.63
Total Assets
821.88
725.42
636.50
554.58
487.28
436.64
398.51
362.96
323.85
274.81

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
93.02
63.22
39.26
76.13
69.27
75.42
52.84
26.63
25.04
44.80
PBT
109.19
122.24
100.48
95.94
83.72
67.23
62.19
46.25
37.33
33.07
Adjustment
0.96
-16.76
-0.23
1.48
4.84
8.66
9.30
11.64
10.70
13.75
Changes in Working Capital
9.17
-16.12
-31.37
2.40
0.20
14.33
-1.12
-22.00
-13.24
4.80
Cash after chg. in Working capital
119.32
89.37
68.87
99.83
88.76
90.22
70.38
35.88
34.79
51.62
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-26.31
-26.15
-29.61
-23.70
-19.49
-14.81
-17.53
-9.25
-9.75
-6.82
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-78.95
-57.34
-36.64
-78.08
-64.23
-30.88
-18.19
-11.77
-25.48
-41.79
Net Fixed Assets
-16.32
-35.95
-17.06
-43.53
-35.54
-5.59
-11.52
-12.45
4.05
-29.04
Net Investments
-34.80
-47.59
5.48
-16.15
-20.70
-14.20
-7.10
-2.72
-16.01
-7.34
Others
-27.83
26.20
-25.06
-18.40
-7.99
-11.09
0.43
3.40
-13.52
-5.41
Cash from Financing Activity
-6.40
-5.18
-4.50
-2.56
-5.75
-37.76
-35.77
-11.41
0.30
-3.42
Net Cash Inflow / Outflow
7.67
0.70
-1.88
-4.50
-0.70
6.77
-1.11
3.45
-0.14
-0.41
Opening Cash & Equivalents
5.75
5.05
6.93
11.44
12.14
5.46
6.57
3.12
3.26
3.75
Closing Cash & Equivalent
13.41
5.75
5.05
6.93
11.44
12.23
5.46
6.57
3.12
3.43

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
335.34
295.98
250.86
216.12
182.92
156.54
134.67
112.11
96.19
81.52
ROA
10.64%
13.70%
12.24%
13.31%
13.48%
12.33%
12.80%
10.09%
9.40%
8.87%
ROE
13.02%
17.04%
15.59%
17.35%
18.32%
17.67%
19.75%
16.63%
17.29%
19.49%
ROCE
17.55%
22.53%
21.82%
24.29%
24.90%
22.30%
22.50%
19.05%
18.51%
21.18%
Fixed Asset Turnover
2.67
2.80
2.90
3.17
3.04
2.81
2.84
3.07
3.19
3.90
Receivable days
91.75
89.63
86.09
84.27
89.34
102.22
112.23
100.99
85.52
89.69
Inventory Days
43.57
44.26
48.72
43.86
39.12
38.19
39.51
41.74
32.36
22.16
Payable days
141.73
110.27
124.63
138.44
126.82
56.60
57.26
47.62
37.21
40.22
Cash Conversion Cycle
-6.41
23.61
10.19
-10.30
1.64
83.82
94.48
95.11
80.67
71.63
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.02
0.12
0.27
0.34
0.59
Interest Cover
58.99
84.45
50.49
67.11
54.61
34.32
16.56
9.55
6.60
4.32

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Lincoln Pharma - Quarterly Results
    13th Feb 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.